BiondVax Pharmaceuticals Correlations
| BVXVDelisted Stock | USD 1.35 0.03 2.17% |
The current 90-days correlation between BiondVax Pharmaceuticals and First Wave BioPharma is 0.14 (i.e., Average diversification). The correlation of BiondVax Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
BiondVax Pharmaceuticals Correlation With Market
Good diversification
The correlation between BiondVax Pharmaceuticals and DJI is -0.11 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BiondVax Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
BiondVax |
Moving together with BiondVax Stock
| 0.65 | PPERY | Bank Mandiri Persero | PairCorr |
| 0.66 | PPERF | Bank Mandiri Persero | PairCorr |
| 0.69 | BKRKF | PT Bank Rakyat | PairCorr |
| 0.69 | TLK | Telkom Indonesia Tbk | PairCorr |
| 0.74 | KO | Coca Cola Sell-off Trend | PairCorr |
| 0.82 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against BiondVax Stock
| 0.9 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.87 | PTAIF | PT Astra International | PairCorr |
| 0.83 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
| 0.82 | SSNLF | Samsung Electronics | PairCorr |
| 0.81 | AA | Alcoa Corp Fiscal Year End 15th of January 2025 | PairCorr |
| 0.76 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.73 | AXP | American Express Fiscal Year End 24th of January 2025 | PairCorr |
| 0.71 | WMT | Walmart Aggressive Push | PairCorr |
| 0.7 | T | ATT Inc Aggressive Push | PairCorr |
| 0.67 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.65 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
| 0.64 | HD | Home Depot Sell-off Trend | PairCorr |
| 0.51 | XOM | Exxon Mobil Corp Sell-off Trend | PairCorr |
| 0.45 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.34 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
Related Correlations Analysis
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BiondVax Stock performing well and BiondVax Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BiondVax Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| FWBI | 5.73 | (1.60) | 0.00 | 1.01 | 0.00 | 8.65 | 65.42 | |||
| SLRX | 4.28 | (0.25) | 0.00 | (0.09) | 0.00 | 9.59 | 27.43 | |||
| SABS | 5.56 | 0.48 | 0.06 | 1.32 | 6.18 | 17.06 | 45.73 | |||
| VCNX | 5.96 | 0.07 | 0.00 | 0.08 | 0.00 | 11.11 | 54.95 | |||
| GOVX | 5.79 | (1.00) | 0.00 | (0.36) | 0.00 | 9.26 | 77.95 | |||
| MOLN | 4.53 | (0.20) | 0.00 | (0.02) | 0.00 | 9.38 | 52.92 | |||
| MLYS | 2.68 | (0.10) | 0.02 | 0.07 | 3.38 | 6.27 | 20.98 | |||
| ANTX | 1.86 | 0.19 | 0.06 | 0.34 | 1.86 | 3.73 | 28.03 | |||
| PHVS | 2.99 | 0.18 | 0.07 | 0.23 | 3.19 | 7.76 | 21.41 | |||
| PEPG | 3.19 | (1.03) | 0.00 | (0.53) | 0.00 | 5.12 | 26.81 |
View BiondVax Pharmaceuticals Related Equities
| Risk & Return | Correlation |
BiondVax Pharmaceuticals Corporate Management
| CPA CPA | Chief Officer | Profile | |
| BSc Eng | Chief Officer | Profile | |
| Tamar BenYedidia | Chief Scientific Officer | Profile | |
| Dalit Fischer | Head RD | Profile | |
| MSc MBA | CEO Director | Profile | |
| Moran LLB | Chief Staff | Profile |
Still Interested in BiondVax Pharmaceuticals?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.